{"id":"placebo-for-etoricoxib","safety":{"commonSideEffects":[]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo for etoricoxib","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:49:31.081992+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:49:43.136396+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo for etoricoxib","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:49:44.030433+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cyclooxygenase-2 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:49:45.389967+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL416146/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:49:45.280435+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials to establish the efficacy of an active drug by comparison. It relies on the placebo effect—the psychological and physiological response to the expectation of treatment rather than any direct molecular action. In this context, it serves as the comparator for etoricoxib, a COX-2 selective inhibitor used for pain and inflammation.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:09.701Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:49:47.443458+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Control arm in clinical trials for etoricoxib efficacy evaluation"}]},"trialDetails":[{"nctId":"NCT01980940","phase":"PHASE1, PHASE2","title":"The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-12-23","conditions":"Osteoarthritis Pain","enrollment":70},{"nctId":"NCT01208207","phase":"PHASE3","title":"A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-09-27","conditions":"Spondylitis, Ankylosing","enrollment":1015},{"nctId":"NCT01208181","phase":"PHASE3","title":"A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-09-27","conditions":"Arthritis, Rheumatoid","enrollment":1404},{"nctId":"NCT05683574","phase":"PHASE3","title":"Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-05-30","conditions":"Third Molar Extraction","enrollment":""},{"nctId":"NCT05308420","phase":"PHASE4","title":"PENG Block vs Intrathecal Morphine in Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Kresimir Oremus, MD","startDate":"2022-04-03","conditions":"Total Hip Arthroplasty, Postoperative Pain","enrollment":60},{"nctId":"NCT01429168","phase":"PHASE4","title":"A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2011-10","conditions":"Osteoarthritis","enrollment":""},{"nctId":"NCT01462370","phase":"PHASE3","title":"Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-11","conditions":"Dysmenorrhea","enrollment":139},{"nctId":"NCT00788710","phase":"PHASE3","title":"A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-10","conditions":"Acute Pain Following a Total Abdominal Hysterectomy","enrollment":430},{"nctId":"NCT00820027","phase":"PHASE3","title":"Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-12-15","conditions":"Pain, Postoperative","enrollment":776},{"nctId":"NCT00746720","phase":"PHASE2","title":"Modulation of the Surgical Inflammatory Response by Etoricoxib","status":"TERMINATED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2006-05","conditions":"Pain, Osteoarthritis, Hip, Postoperative Pain","enrollment":23},{"nctId":"NCT04462666","phase":"PHASE2","title":"Oral Huzhang Granules for Acute Gouty Arthritis","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2020-07-01","conditions":"Gouty Arthritis","enrollment":267},{"nctId":"NCT02954484","phase":"PHASE3","title":"Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2015-04","conditions":"Pain, Postoperative","enrollment":116},{"nctId":"NCT01246362","phase":"PHASE2","title":"Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Singapore General Hospital","startDate":"2011-07","conditions":"Knee Osteoarthritis","enrollment":65},{"nctId":"NCT02750917","phase":"PHASE3","title":"Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Foisor Orthopedics Clinical Hospital","startDate":"2014-09","conditions":"Postoperative Pain","enrollment":120},{"nctId":"NCT02534610","phase":"NA","title":"Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Foisor Orthopedics Clinical Hospital","startDate":"2014-01","conditions":"Postoperative Pain","enrollment":165},{"nctId":"NCT01259830","phase":"PHASE4","title":"Effectiveness of Etoricoxib as an Additive Analgesic to Epidural Analgesia in Colon or Rectal Fast-track Surgery","status":"TERMINATED","sponsor":"Claudia Spies","startDate":"2011-03","conditions":"Post-operative Pain","enrollment":81},{"nctId":"NCT01619150","phase":"PHASE2","title":"A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain","status":"COMPLETED","sponsor":"C4Pain","startDate":"2012-07","conditions":"Osteoarthritis","enrollment":39},{"nctId":"NCT00954785","phase":"PHASE4","title":"Etoricoxib in Acute Ankle Ligament Sprains","status":"WITHDRAWN","sponsor":"University of Cape Town","startDate":"2009-11","conditions":"Sprain","enrollment":""},{"nctId":"NCT01088256","phase":"PHASE2","title":"Efficacy of Etoricoxib on Peripheral Hyperalgesia","status":"TERMINATED","sponsor":"Ruhr University of Bochum","startDate":"2011-02","conditions":"Causalgia, Polyneuropathy, Postherpetic Neuralgia","enrollment":9},{"nctId":"NCT01271348","phase":"PHASE1","title":"Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise","status":"COMPLETED","sponsor":"X-pert Med GmbH","startDate":"2011-01","conditions":"Muscle Pain","enrollment":50},{"nctId":"NCT01304069","phase":"PHASE1","title":"Effect of Celecoxib and Etoricoxib on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2011-01","conditions":"Healthy","enrollment":12},{"nctId":"NCT01264237","phase":"PHASE4","title":"Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain","status":"UNKNOWN","sponsor":"Analgesic Solutions","startDate":"2011-03","conditions":"Postherpetic Neuralgia, Neuralgia","enrollment":120},{"nctId":"NCT01148303","phase":"PHASE4","title":"Trial of Etoricoxib (Arcoxia) Taken Prophylactically to Prevent Ramadan Headache","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2010-07","conditions":"Headache, Fasting, Fasting Headache","enrollment":220},{"nctId":"NCT00970112","phase":"PHASE2, PHASE3","title":"Dexamethasone and Etoricoxib for Pain Prevention Following Periodontal Surgery","status":"COMPLETED","sponsor":"Universidade Estadual de Ponta Grossa","startDate":"2008-11","conditions":"Pain Control","enrollment":20},{"nctId":"NCT01017380","phase":"PHASE3","title":"Preemptive Analgesia in Cruciate Reconstruction","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2008-01","conditions":"Anterior Cruciate Ligament Injury","enrollment":30},{"nctId":"NCT00440739","phase":"PHASE4","title":"Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2005-09","conditions":"Pain","enrollment":128}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL416146"},"_approvalHistory":[],"publicationCount":187,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo for etoricoxib","genericName":"Placebo for etoricoxib","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect. Used for Control arm in clinical trials for etoricoxib efficacy evaluation.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:49:47.443458+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}